China Cord Blood Corp. (NYSE:CO)

CAPS Rating: 1 out of 5

The company operates as a cord blood bank in China, providing laboratory testing, cord blood collection, stem cell storage services, and hematopoietic stem cell processing.

Recs

0
Player Avatar OklaBoston (< 20) Submitted: 6/18/2012 8:07:12 PM : Outperform Start Price: $2.76 CO Score: -10.17

Cash flow has gone from negative to positive this year.

Member Avatar OklaBoston (< 20) Submitted: 8/6/2012 9:07:51 AM
Recs: 0

Insider ownership is almost 63%. That's good evidence to me that cash flow won't be going negative again any time soon.

Featured Broker Partners


Advertisement